Literature DB >> 6444721

Isozymes of human phosphofructokinase: identification and subunit structural characterization of a new system.

S Vora, C Seaman, S Durham, S Piomelli.   

Abstract

The existence of a five-membered isozyme system for human phosphofructokinase (PFK; ATP:D-fructose-6-phosphate 1-phosphotransferase, EC 2.7.1.11) has been demonstrated. These multimolecular forms result from the random polymerization of two distinct subunits, M (muscle type) and L (liver type), to form all possible tetrameters-i.e., M(4), M(3)L, M(2)L(2), ML(3), and L(4). Partially purified muscle and liver PFKs were hybridized by dissociation at low pH and then recombination at neutrality. Three hybrid species were generated in addition to the two parental isozymes, to yield an entire five-membered set. The various species could be consistently and reproducibly separated from one another by DEAE-Sephadex chromatography at pH 8.0 with a concave elution gradient of salt. Under similar experimental conditions, erythrocyte PFK from hemolysates was also resolved into five species chromatographically indistinguishable from those produced in the above experiment. Immunological and kinetic studies of the isozymes provided corroborative evidence to support the proposed subunit structures. Erythrocyte PFK was found to have kinetic properties intermediate between those of muscle and liver PFK and was neutralized only 50% by an antiserum against muscle PFK that completely neutralized muscle PFK. These data demonstrate that muscle and liver PFKs are distinct homotetramers-i.e., M(4) and L(4), respectively-whereas erythrocyte PFK is a heterogeneous mixture of all five isozymes. The structural heterogeneity of erythrocyte PFK provides a molecular genetic basis for the differential organ involvement observed in some inherited PFK deficiency states in which myopathy or hemolysis or both can occur.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6444721      PMCID: PMC348208          DOI: 10.1073/pnas.77.1.62

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  PHOSPHOFRUCTOKINASE DEFICIENCY IN SKELETAL MUSCLE. A NEW TYPE OF GLYCOGENOSIS.

Authors:  S TARUI; G OKUNO; Y IKURA; T TANAKA; M SUDA; M NISHIKAWA
Journal:  Biochem Biophys Res Commun       Date:  1965-05-03       Impact factor: 3.575

2.  Studies on structure of human erythrocyte phosphofructokinase.

Authors:  N S Karadsheh; K Uyeda; R M Oliver
Journal:  J Biol Chem       Date:  1977-05-25       Impact factor: 5.157

3.  Rabbit brain phosphofructokinase. Comparison of regulatory properties with those of other phosphofructokinase isozymes.

Authors:  M Y Tsai; R G Kemp
Journal:  J Biol Chem       Date:  1974-10-25       Impact factor: 5.157

4.  Purification and properties of sheep liver phosphofructokinase.

Authors:  D J Brock
Journal:  Biochem J       Date:  1969-06       Impact factor: 3.857

5.  Letter: Red-cell phosphofructokinase deficiency.

Authors:  M R Boulard; M C Meienhofer; M Bois; M Reviron; Y Najean
Journal:  N Engl J Med       Date:  1974-10-31       Impact factor: 91.245

6.  Studies on the association behaviour of human-erythrocyte phosphofructokinase.

Authors:  G Zimmermann; K W Wenzel; J Gauer; E Hofmann
Journal:  Eur J Biochem       Date:  1973-12-17

7.  A new type of phosphofructokinase deficiency hereditary nonspherocytic hemolytic anemia.

Authors:  S Miwa; T Sato; H Murao; M Kozuru; H Ibayashi
Journal:  Nihon Ketsueki Gakkai Zasshi       Date:  1972-02

8.  Rabbit muscle phosphofructokinase: studies of the subunit molecular weight and structure. Isolation of carboxymethylated cysteinyl peptides and sedimentation equilibrium studies.

Authors:  C J Coffee; R P Aaronson; C Frieden
Journal:  J Biol Chem       Date:  1973-02-25       Impact factor: 5.157

9.  The distribution of two chromatographically distinguishable forms of phosphofructokinase in the tissues of the rat.

Authors:  C B Taylor; M Bew
Journal:  Biochem J       Date:  1970-10       Impact factor: 3.857

10.  Studies on multimolecular forms of phosphofructokinase in rat tissues.

Authors:  T Tanaka; T An; Y Sakaue
Journal:  J Biochem       Date:  1971-03       Impact factor: 3.387

View more
  31 in total

1.  Alteration of the levels of the M-type 6-phosphofructo-1-kinase mRNA isoforms during neonatal maturation of heart, brain and muscle.

Authors:  Y Mhaskar; G Armour; G Dunaway
Journal:  Mol Cell Biochem       Date:  2000-11       Impact factor: 3.396

2.  Diagnosis of glycogen storage disease.

Authors:  Y S Shin
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

Review 3.  Skeletal muscle disorders of glycogenolysis and glycolysis.

Authors:  Richard Godfrey; Ros Quinlivan
Journal:  Nat Rev Neurol       Date:  2016-05-27       Impact factor: 42.937

4.  Characterization of the enzymatic defect in late-onset muscle phosphofructokinase deficiency. New subtype of glycogen storage disease type VII.

Authors:  S Vora; S DiMauro; D Spear; D Harker; M J Danon
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

5.  Nature of the subunits of the 6-phosphofructo-1-kinase isoenzymes from rat tissues.

Authors:  G A Dunaway; T P Kasten
Journal:  Biochem J       Date:  1987-03-15       Impact factor: 3.857

6.  Phosphofructokinase activity in fibroblasts aneuploid for chromosome 21.

Authors:  K G Annerén; J R Korenberg; C J Epstein
Journal:  Hum Genet       Date:  1987-05       Impact factor: 4.132

7.  Regional assignment of human liver-type 6-phosphofructokinase to chromosome 21q22.3 by using somatic cell hybrids and a monoclonal anti-L antibody.

Authors:  M Van Keuren; H Drabkin; I Hart; D Harker; D Patterson; S Vora
Journal:  Hum Genet       Date:  1986-09       Impact factor: 4.132

8.  Phosphofructokinase activity in fibroblasts from patients with Alzheimer's disease and age- and sex-matched controls.

Authors:  N R Sims; J P Blass
Journal:  Metab Brain Dis       Date:  1986-03       Impact factor: 3.584

9.  Nonsense mutation in the phosphofructokinase muscle subunit gene associated with retention of intron 10 in one of the isolated transcripts in Ashkenazi Jewish patients with Tarui disease.

Authors:  O Vasconcelos; K Sivakumar; M C Dalakas; M Quezado; J Nagle; M Leon-Monzon; M Dubnick; D C Gajdusek; L G Goldfarb
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

10.  Phosphofructo-1-kinase deficiency leads to a severe cardiac and hematological disorder in addition to skeletal muscle glycogenosis.

Authors:  Miguel García; Anna Pujol; Albert Ruzo; Efrén Riu; Jesús Ruberte; Anna Arbós; Anna Serafín; Beatriz Albella; Juan Emilio Felíu; Fátima Bosch
Journal:  PLoS Genet       Date:  2009-08-21       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.